Chromosomal instability has been described in patients affected by various tumors. We previously reported a high sensitivity to fragile sites induction by aphidicolin in lymphocytes from patients affected by neuroblastoma and in those from their parents. In the search for the most suitable clastogenic agent to enhance the possible differences between healthy controls and patients affected by tumors, we have now tested two otherdrugs: bleomycin, a radiomimetic agent already used in vitro on chromosomes of patients affected by other tumors and arabinoside cytosine, an inhibitor of DNA polymerases alfa and beta. We observed a high sensitivity to bleomycin both in patients and in their parents, but to arabinoside cytosine only in NB patients. Moreover, the two drugs induced more fragile sites in 1p in patients and in their parents than in healthy controls. This phenomenon, which we already observed after treatment with aphidicolin, might be related to the frequent deletions and loss of heterozigosity in 1p in neuroblastoma cells.

Vernole, P., Tedeschi, B., Caporossi, D., Nicoletti, B. (1993). SENSITIVITY TO BLEOMYCIN AND ARABINOSIDE CYTOSINE IN LYMPHOCYTES OF PATIENTS AFFECTED BY NEUROBLASTOMA AND IN THOSE OF THEIR PARENTS. CANCER BIOTHERAPY, 8(1), 87-94.

SENSITIVITY TO BLEOMYCIN AND ARABINOSIDE CYTOSINE IN LYMPHOCYTES OF PATIENTS AFFECTED BY NEUROBLASTOMA AND IN THOSE OF THEIR PARENTS

VERNOLE, PATRIZIA;
1993-01-01

Abstract

Chromosomal instability has been described in patients affected by various tumors. We previously reported a high sensitivity to fragile sites induction by aphidicolin in lymphocytes from patients affected by neuroblastoma and in those from their parents. In the search for the most suitable clastogenic agent to enhance the possible differences between healthy controls and patients affected by tumors, we have now tested two otherdrugs: bleomycin, a radiomimetic agent already used in vitro on chromosomes of patients affected by other tumors and arabinoside cytosine, an inhibitor of DNA polymerases alfa and beta. We observed a high sensitivity to bleomycin both in patients and in their parents, but to arabinoside cytosine only in NB patients. Moreover, the two drugs induced more fragile sites in 1p in patients and in their parents than in healthy controls. This phenomenon, which we already observed after treatment with aphidicolin, might be related to the frequent deletions and loss of heterozigosity in 1p in neuroblastoma cells.
1993
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore BIO/13 - BIOLOGIA APPLICATA
English
Con Impact Factor ISI
COMMON FRAGILE SITES; PERIPHERAL-BLOOD LYMPHOCYTES; NEURO-BLASTOMA; CHROMOSOME-DAMAGE; BONE-MARROW; CANCER; APHIDICOLIN; CELLS; SUSCEPTIBILITY; ABNORMALITIES
Vernole, P., Tedeschi, B., Caporossi, D., Nicoletti, B. (1993). SENSITIVITY TO BLEOMYCIN AND ARABINOSIDE CYTOSINE IN LYMPHOCYTES OF PATIENTS AFFECTED BY NEUROBLASTOMA AND IN THOSE OF THEIR PARENTS. CANCER BIOTHERAPY, 8(1), 87-94.
Vernole, P; Tedeschi, B; Caporossi, D; Nicoletti, B
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/50283
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact